PubRank

An Investigation of TAS-119 Monotherapy and in Combination With Docetaxel

Clinical Trial ID NCT02448589

PubWeight™ 0.86‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02448589

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009 77.71
2 Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 43.81
3 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 2006 11.26
4 AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003 3.50
5 Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov 2011 3.43
6 Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 2009 2.97
7 Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 2006 2.88
8 Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 2007 2.45
9 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev 2011 2.08
10 Individual patient data analysis to assess modifications to the RECIST criteria. Eur J Cancer 2008 1.94
11 Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell 2013 1.85
12 Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2006 1.84
13 Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer. Clin Cancer Res 2008 1.50
14 Aurora kinases as targets for cancer therapy. Cancer Treat Rev 2007 1.33
15 Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. Clin Cancer Res 2007 1.20
16 Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC). Ann Surg Oncol 2007 1.15
17 Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors. Clin Cancer Res 2011 1.14
18 Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma. Cancer Lett 2001 0.89
19 Aurora-A Kinase as a Promising Therapeutic Target in Cancer. Front Oncol 2016 0.86
20 Expression of serine threonine kinase 15 is associated with poor differentiation in lung squamous cell carcinoma and adenocarcinoma. Pathol Int 2006 0.86
Next 100